CE mark for Roche's 3 in 1 test:
This article was originally published in Clinica
Roche Diagnostics' new test for HIV and hepatitis viruses in donor blood and tissues is now approved for sale in Europe. Us of the cobas s 201 system will obviate the need for three separate tests for HIV, Hepatitis A and Hepatitis B, while new tests can be added to the system later. The test will be commercially available later this year.
You may also be interested in...
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.
Stada has appointed a head of digital communications; PGEU elects new chair and vice-chair; and the new UK health claims committee unveils its first members.